‘Starpharma has since also met with the FDA to discuss this submission. Starpharma will provide an update on this submission upon receiving an outcome from the FDA.’
What the HELL?
This is a formal dispute resolution process. The FDA will have a mandated number of days and/or agreed date to respond to Starpharma with their decision.
So where is the date/timeline Starpharma? Why is this not communicated to long-suffering shareholders?
This is just not good enough and shows to me that the new CEO doesn’t get it either and intends to treat shareholders as mugs and mushrooms as we have been for decades.
Another red flag for me.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-5
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.29M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 15000 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.6¢ | 1275 | 1 |
View Market Depth
| Last trade - 09.08am 12/07/2024 (20 minute delay) ? |
| SPL (ASX) Chart |
Day chart unavailable